Patients: Twenty patients receiving chronic haemodialysis and with adequately controlled blood pressure were included in the study. Fourteen patients were randomised to candesartan cilexetil and ...
Although the main objective of the study was to investigate the pharmacokinetics of candesartan cilexetil in haemodialysis patients, the control group receiving placebo was deemed necessary since ...